Sorry, obviously meant for Rachel not the list! Was only a matter of time
till I made the standard mistake, hopefully for the first and last time...
Tim
-----Original Message-----
From: Rachel Cottam [mailto:[log in to unmask]]
Sent: 28 June 2001 11:34
To: [log in to unmask]
Subject: FW: Drug Companies - talk at the ICA
> -----Original Message-----
> From: Rachel Cottam
> Sent: 28 June 2001 11:32
> To: [log in to unmask]
> Subject: Drug Companies - talk at the ICA
>
> Thursday July 12th
> Drug Companies: Saints or Demons?
> The ICA Economist Debate
> ICA Theatre £8/£7/£6
> 7.00pm
> How can drug companies balance an ethical policy with the need to recoup
> costs for research and development of new drugs? Are new models needed to
> ensure greater access by poor populations to relevant and affordable
> medicines? How can we ensure that multinational drug companies remain
> accountable to a constituency wider than that of their shareholders? Are
> people just uncomfortable with the idea of people in medicine making
> money?
>
> Speakers include Gill Samuels, Senior Director, Science Policy and
> Scientific Affairs at Pfizer, who has contributed to the discovery of
> several new medicines, now marketed, and worked on the UK Government
> Commission Intellectual Property Rights and the European Biotechnology
> Patent Directive; Simon Zadek, chair of the Institute of Social and
> Ethical Accountability; Daniel Berman, coordinator of MSF's Access to
> Essential Medicines Campaign, and previously vice president of the pr
> agency for pharmaceutical giants including Pfizer and Roche; and David
> Earnshaw, previously director of European Government Affairs and Public
> Policy at SmithKline Beecham, and now head of the Brussels office of Oxfam
> International. In the chair is Shereen El Feki, healthcare correspondent
> at The Economist.
> Tickets and Information: 0207 930 3647
>
>
|